In other news, Harvard University’s Office of Technology Development and Carl Zeiss MicroImaging GmbH, a 100 percent subsidiary of Carl Zeiss AG, have signed a licensing agreement permitting Zeiss to use the coherent anti-stokes Raman-scattering microscopy technology developed at Harvard in its confocal and multiphoton microscopes. This will make it possible to image biochemically important molecules in living cells and organisms without the need to label them with a dye. When combined with fluorescence imaging of biological and technical specimens, the technique will contribute to a more in-depth understanding of biological and biochemical processes. It also may be used for testing new active ingredients in the pharmaceutical industry or for medical diagnostics.